| 1 |
28482130 | Candidate-Gene Study of Functional Polymorphisms in SLCO1B1 and CYP3A4/5 and the Cholesterol-Lowering Response to Simvastatin. | 2017 May |
1 |
| 2 |
27236640 | Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. | 2016 Jun |
1 |
| 3 |
25051018 | CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort. | 2014 Oct |
1 |
| 4 |
20231858 | Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians. | 2011 Apr |
1 |
| 5 |
20207952 | Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study. | 2010 Jun |
2 |
| 6 |
19530969 | Statin regulation of CYP3A4 and CYP3A5 expression. | 2009 Jun |
1 |
| 7 |
18727922 | CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia. | 2008 Dec |
1 |
| 8 |
15284534 | Lipid-lowering response to statins is affected by CYP3A5 polymorphism. | 2004 Aug |
2 |